Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH

Predicting response to alkylating chemotherapy in breast cancer patients using array comparative genomic hybridization.

(2010) MA Vollebergh et al.   CANCER RESEARCH

Methylation not a frequent “second hit” in tumors with germline BRCA mutations

(2009) Amy M. Dworkin et al.   Familial Cancer

Deletion of Exons 1a–2 of BRCA1: A Rather Frequent Pathogenic Abnormality

(2009) Ans M.W. van den Ouweland et al.   Genetic Testing and Molecular Biomarkers

Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers

(2008) Tair Kontorovich et al.   BREAST CANCER RESEARCH AND TREATMENT

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH

(2008) Simon A. Joosse et al.   BREAST CANCER RESEARCH AND TREATMENT

How Large a Training Set is Needed to Develop a Classifier for Microarray Data?

(2008) K. K. Dobbin et al.   CLINICAL CANCER RESEARCH

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach

(2008) Marc Tischkowitz et al.   EUROPEAN JOURNAL OF HUMAN GENETICS